ÂÜÀòÂÒÂ×

Eduardo Fernández Albiñana currently serves as SVP of Business Operations and Business Development at Exeltis Pharmaceuticals since June 2012, contributing to the Chemo Group Branded Pharmaceuticals Division. Additionally, Eduardo has been a Member of the Board of Advisors for Viramal Limited since February 2020. Prior experience includes roles as Senior Manager at Capgemini, focusing on strategy and management consulting for consumer packaged goods and healthcare from 2005 to August 2012, and as Senior Consultant at Ayming from 2003 to 2005, concentrating on various industries with an emphasis on chemicals and pharmaceuticals. Prior to that, Eduardo worked as a Consultant at Pricewaterhouse Coopers from 2001 to 2003, providing business consulting services for healthcare and consumer goods. Eduardo holds an Executive MBA from IESE Business School and has completed other degrees from prestigious institutions, including The Wharton School, Université libre de Bruxelles, Universidad Pontificia Comillas, and Columbia Business School, with a focus on engineering and business strategies.